Clinical Trial Update: Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated near-infrared LED therapy for Leber's Hereditary Optic Neuropathy; the study was terminated with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leber Hereditary Optic Neuropathy

Drugs mentioned

• NIR-LED therapy

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Leber's Hereditary Optic Neuropathy (LHON) | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2014-09-29